
Biodesix strengthens lung nodule testing strategy with Nodify CDT test
BOULDER -- Biodesix, Inc. announced it is extending its blood-based testing portfolio with the release of the Nodify CDT TM test, designed to help physicians identify patients with lung nodules at... Read More
Wednesday March 4, 2020 0 comments